ctDNA MRD status predicts survival and adjuvant chemo benefit in resected colorectal liver metastas

ASCO 2026: Updates in bladder cancer

ASCO 2026: Updates in renal cancer

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management

ASCO 2026: Highlights and analysis

Implanted tile-based radiation shows promise compared with stereotactic radiotherapy for brain metastases

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases

Pembrolizumab alone achieves bladder preservation and ctDNA predicts outcomes in muscle-invasive bladder cancer

AMVAC plus nivolumab in muscle-invasive bladder cancer preserves bladder and predicts metastatic control with ctDNA

225Ac-PSMA-trillium shows high PSA response and favourable safety in metastatic castration-resistant prostate cancer

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns